HIV/HCV Main Page

Medical Advocates
HIV/HCV Coinfection

Main Page

New and Noteworthy       Treatment
General Reports              Drugs
Clinical Variants              Quality of Life
Extrahepatic                    HIV/HCV/HBV
Pathogenesis                   Reproduction Challenges
Natural History
ARVs HIV/HCV Progression
Special Populations
Diagnostics
Screening/Monitoring
Epidemiology/National Challenges

Disease Index Main New/Newsworthy Home Page

Last Update: September 04, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

August 2008

XVII International AIDS Conference Citations

Treatment of HCV/HIV co-infection in a diverse population with substantial co-morbidity
B. Johnston, M. Carasso E. Marchand, et al
Long-term outcomes after peg-IFN plus pibavirin in HIV/HCV-cirrhotic patients with hypersplenism undergoing
partial splenic embolization (PSE)
A. Moreno, R. Bárcena, C. Quereda
HCV co-infection and risk of acute myocardial and cerebrovascular disease among HIV-infected patients
in the pre-HAART and HAART eras
R. Bedimo, A. Westfall, M. Mugavero, et al
Barriers to hepatitis C treatment in HIV/HCV-coinfected patients in an HIV reference center in Argentina
E. Socías, N. Laufer, M. Cabrini
HCV is emerging as an STI among HIV-infected MSM: a threat to the MSM community?
A.T. Urbanus, T.J.W. van de Laar, J. Schinkel, et al
Acute hepatitis C in HIV-infected men who have sex with men in France in 2006 and 2007: HEPAIG study,
behavioural results
A. Velter, C. Larsen, J.-Y. Le Talec, et al
Characteristics of HIV-infected women in Georgia and factors associated with HCV co-infection
N. Chkhartishvili, L.A. McNutt, P.F. Smith, et al
Genomic analysis of hepatitis C viral factors related to IFN response in HIV-co-infected patients
F. Bolcic, L. Bull , M.L. Martinez, et al
HCV relapses upon completion of peg-interferon plus ribavirin in HIV-infected patients: rate, timing and predictors
P. Barreiro, M. Nuñez, I. Santos, et al
Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either
pegylated interferon -2a or -2b
E. Vispo, P. Barreiro, S. Rodriguez-Novoa, et al
Responding to HIV/HCV co-infection through advocacy & social policy development through PLHIV/HCV
C. Price, S. Lal, K. Buchanan, et al
Integrating HIV prevention with hepatitis C co-infection programs
L. Scaccabarrozzi
Gender and Hepatitis C co-infection in a cohort of Hispanic persons living with HIV AIDS
A. Mayor , D. Fernandez , E. Rios-Olivaresk, et al
Integrated care for HIV-HCV co-infection: is the model effective?
D. Tider , J. Weiss , A. Stivala, et al
The effect of HCV genotype on mortality among HIV-co-infected individuals receiving antiretroviral treatment
within a populational cohort
N.A. Jahnke, B. Yip, V.D. Lima, et al
Transient elastography (TE) (FibroScan) in the hepatic assessment of co-infected HIV-HCV patients receiving HAART
G. Panos, P. Holmes, S. Mandalia, et al
Evidences of GBV-C viral interference on HIV-HCV co-infection
G.L. Baggio-Zappia , A.J. Barbosa, M.K.C. Brunialti, et al
Pilot trial of milk thistle in HIV/hepatitis C co-infection
G. Carter1 , J. Godbold , R. MacKay
Factors associated with fatigue in HIV/HCV co-infected patients participating in the prospective
ANRS Co13 (HEPAVIH) French Cohort study
V. Villes, F. Dabis, B. Spire
Increase in bilirubin in HIV/HCV coinfected patients treated with atazanavir following initiation of peginterferon
plus ribavirin
S. Rodriguez-Novoa, J. Morello, M. Gonzalez, et al
POWERPOINT PRESENTATION
Mental Health, Substance Use, and HIV/HCV Coinfection Treatment
J Weiss
POWERPOINT PRESENTATION
A summary of state of the art in non-invasive diagnosis of liver disease, liver transplantation, and
treatments on the horizon for hepatitis virus co-infected patients
J Rockstroh

Journal Citations

HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment
is associated with virologic relapse.
de Felipe B, Leal M, Soriano-Sarabia N, et al J Viral Hepat. 2008 Aug 28.
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review
and meta-analysis.
Wyatt CM, Malvestutto C, Coca SG, et alAIDS. 2008 Sep 12;22(14):1799-807.
FULL-TEXT PDF ARTICLE
Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and
more advanced hepatic fibrosis?
Verma S, Goldin RD, Main J., et al BMC Res Notes. 2008 Jul 15;1(1):46
HIV and hepatitis C coinfection.
Matthews GV, Dore GJ.J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1)
Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with
individual data.
Leroy V, Halfon P, Bacq Y, et alClin Biochem. 2008 Jul 11
Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.
Tatsunami S, Mimaya J, Shirahata A, et al Int J Hematol. 2008 Aug 2.
Acute HCV in HIV-positive individuals - a review.
Danta M, Dusheiko GM.Curr Pharm Des. 2008;14(17):1690-7.

General Reports

Journal Papers, Abstracts, and Commentaries

HIV and hepatitis C coinfection.
Matthews GV, Dore GJ.
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1)
Abstract

Acute HCV in HIV-positive individuals - a review.
Danta M, Dusheiko GM.
Curr Pharm Des. 2008;14(17):1690-7.
Abstract

Hepatitis C Virus Coinfection Does Not Affect CD4 Restoration in HIV-Infected Patients after Initiation of
Antiretroviral Therapy.
Yacisin K, Maida I, Ríos MJ, et al
AIDS Res Hum Retroviruses. 2008 Jul 1.
Abstract

A WEEK IN REVIEW FEATURED REPORT
Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ, Maida I, Soriano V, Núňez M.
J Hepatol. 2008 May 5.
Abstract

Acute hepatitis C virus infection.
Irving W, Salmon D, Boucher C, Hoepelman I
Euro Surveill. 2008 May 22;13(21)
Abstract

The Symptom Experience of HIV/HCV-Coinfected Adults.
Bova C, Jaffarian C, Himlan P,et al
J Assoc Nurses AIDS Care. 2008 May-Jun;19(3):170-80.
Abstract

HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
Blackard JT, Sherman KE.
J Viral Hepat. 2008 Jan 17
Abstract

Risk factors for hepatitis C virus infection in individuals infected with the HIV.
Wolff FH, Fuchs SC, Barcellos NT, et al
Dig Liver Dis. 2007 Dec 18
Abstract

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in
HIV patients with chronic hepatitis C.
Martin-Carbonero L, Nuñez M, Mariño A. et al
AIDS. 2008 Jan 2;22(1):15-21.
Abstract

Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count
Inglot M, Szymczak A, Gładysz A, et al
Przegl Epidemiol. 2007;61(3):535-43.
Abstract

Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral
therapy in chronic human immunodeficiency virus type 1 disease.
Santin M, Mestre M, Shaw E, et al
Eur J Clin Microbiol Infect Dis. 2007 Oct 16;
Abstract

Hepatitis C in the HIV-infected patient.
McGovern BH.
J Acquir Immune Defic Syndr. 2007 Jul 1;45
Abstract

Risk Factors for Grade 3-4 Liver Enzyme Elevation in HIV and Hepatitis C Coinfected
Patients on Combination Antiretroviral Therapy.
Chihrin S, Antoniou T, Raboud J, et al
AIDS Patient Care STDS. 2007 Jul;21(7):469-78.
Abstract

Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-
monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
Thein H, Maruff P, Krahn M, et al
HIV Med. 2007 Apr;8(3):192-202
Abstract
.

Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors:
Possible protective effect of infecting HCV genotype on HIV disease progression
Morsica G, Bagaglio S, Ghezzi S, et al
J Clin Virol. 2007 Apr 12
Abstract

The Association of Human Immunodeficiency Virus Infection with Spontaneously Resolved
Hepatitis C Virus Infection and Level of Viremia Among Injection Drug Users.
Seal KH, Monto A, Dove L, et al
Dig Dis Sci. 2007 Apr 19;
Abstract

Effect of Exposure to Injection Drugs or Alcohol on Antigen-Specific Immune Responses in HIV
and Hepatitis C Virus Coinfection.
Graham CS, Wells A, Edwards EM, et al
J Infect Dis. 2007 Mar 15;195(6):847-56.
Abstract

Hepatitis C virus coinfection and superinfection
Blackard JT, Sherman KE.
J Infect Dis. 2007 Feb 15;195(4):519-24.
Abstract

Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
Valle Tovo C, Alves de Mattos A, Ribeiro de Souza A. et al
Liver Int. 2007 Feb;27(1):40-6.
Abstract

Factors Associated with Seronegative Chronic Hepatitis C Virus Infection in HIV Infection.
Chamie G, Bonacini M, Bangsberg DR, et al
Clin Infect Dis. 2007 Feb 15;44(4):577-83.
Abstract

FULL TEXT ARTICLE
Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV
coinfection.
Kim AY, zur Wiesch JS, Kuntzen T, et al
PLoS Med. 2006 Dec;3(12):e492.
Paper

Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.
Nunez M, Soriano V, Lopez M, et al
Clin Infect Dis. 2006 Nov 1;43(9):1209-12.
Abstract

Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus-
Coinfected Patients.
Bollepalli S, Mathieson K, Bay C, et al
Sex Transm Dis. 2006 Sep 28;
Abstract

HIV Coinfection with Hepatitis C and Hepatitis B.
Smith JO, Sterling RK.
Curr Infect Dis Rep. 2006 Sep;8(5):409-18.
Abstract

Drug abuse, innate immunity and hepatitis C virus.
Zhang T, Li Y, Ho WZ.
Rev Med Virol. 2006 Aug 25;16(5):311-327
Abstract

Risk factors for HIV infection among patients infected with hepatitis C virus.
Silva AC, Barone AA.
Rev Saude Publica. 2006 Jun;40(3):482-8.
Abstract

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral
therapy.
Sullivan PS, Hanson DL, Teshale EH, et al
AIDS. 2006 May 12;20(8):1171-1179.
Abstract

HIV/Hepatitis C Virus-Coinfected Patients With Normal Alanine Aminotransferase Levels.
Gonzalez SA, Liu RC, Edlin BR, et al
J Acquir Immune Defic Syndr. 2006 Apr 15;41(15):582-589.
Abstract

Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection.
Tan YJ, Lim SG, Hong W.
Curr HIV Res. 2006 Jan;4(1):21-30.
Abstract

Health Values of Patients Coinfected With HIV/Hepatitis C: Are Two Viruses Worse Than One?
Mrus JM, Sherman KE, Leonard AC, et al
Med Care. 2006 Feb;44(2):158-166
Abstract

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, et al
AIDS. 2006 Jan 2;20(1):49-57.
Abstract

Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and
cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.
Bagaglio S, Cinque P, Racca S,
AIDS. 2005 Oct;19 Suppl 3:S151-65.
Abstract

Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C
virus-co-infected patients.
Kresina TF, Eldred L, Bruce RD, Francis H.
AIDS. 2005 Oct;19 Suppl 3:S221-S226.
Abstract

Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and
HIV/HCV-co-infected veterans.
Goulet JL, Fultz SL, McGinnis KA, Justice AC.
AIDS. 2005 Oct;19 Suppl 3:S99-S105.
Abstract

HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC?
Mauss S, Rockstroh JK.
J Antimicrob Chemother. 2005 Aug 22
Abstract

Update on Hepatitis B and C Coinfection in HIV.
Yachimski P, Chung RT.
Curr Infect Dis Rep. 2005 Jul;7(4):299-308
Abstract

FULL-TEXT ARTICLE
Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive
patients
Braitstein P, Yip B, Montessori V, et al
CMAJ 2005;173 160-164
Paper

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B
viruses and alcohol.
Salmon-Ceron D, Lewden C, Morlat P, et al
J Hepatol. 2005 Jun;42(6):799-805.
Abstract

Detection of Hepatitis C Virus (HCV) in Serum and Peripheral-Blood Mononuclear Cells from
HCV-Monoinfected and HIV/HCV-Coinfected Persons.
Blackard JT, Smeaton L, Hiasa Y, et al
J Infect Dis. 2005 Jul 15;192(2):258-65.
Abstract

Use of Community-Based, Directly Observed Therapy for HIV Infection: Lessons
Learned for Treatment of Hepatitis C Virus Infection.
Flanigan TP, Taylor LE, Mitty JA.
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S346-8.
Abstract

Integrating Treatment for Hepatitis C Virus Infection into an HIV Clinic.
Clanon KA, Johannes Mueller J, Harank M.
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S362-6.
Abstract

Effect of Hepatitis C Virus (HCV) Genotype on HCV and HIV-1 Disease.
Yoo TW, Donfield S, Lail A, et al
J Infect Dis. 2005 Jan 1;191(1):4-10.
Abstract

Hepatitis C Virus Coinfection Increases Mortality in HIV-Infected Patients in the
Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort Study.
Anderson KB, Guest JL, Rimland D, et al
Clin Infect Dis. 2004 Nov 15;39(10):1507-13.
Abstract

Management of the coinfected patient: human immunodeficiency virus/hepatitis
B and human immunodeficiency virus/hepatitis C.
Murphy MJ, Wilcox RD.
Am J Med Sci. 2004 Jul;328(1):26-36.
Abstract

HIV and hepatitis C coinfection within the CAESAR study.
Amin J, Kaye M, Skidmore S, et al
HIV Med. 2004 May;5(3):174-179.
Abstract

Interaction between HIV-1 and HCV infections: towards a new entity?
Winnock M, Salmon-Ceron D, Dabis F, Chene G.
J Antimicrob Chemother. 2004 Apr 2
Abstract

Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects Initiating Highly
Active Antiretroviral Therapy.
Blackard JT, Yang Y, Bordoni P, et al
J Infect Dis. 2004 Apr 15;189(8):1472-81.
Abstract

Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology,
natural history, therapeutic options and clinical management.
Soriano V, Miro JM, Garcia-Samaniego J, Torre-Cisneros J, et al
Viral Hepat. 2004 Jan; 11(1): 2-17
Abstract

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish
recommendations.
Soriano V, Miro JM, Garcia-Samaniego J, Torre-Cisneros J, et al
Viral Hepat. 2004 Jan; 11(1): 2-17
Abstract

Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Dynamics during
HCV Treatment in HCV/HIV Coinfection.
Torriani FJ, Ribeiro RM, Gilbert TL, et al
Infect Dis. 2003 Nov 15;188(10):1498-507.
Abstract

Hepatitis C in the HIV-Infected Person.
Sulkowski MS, Thomas DL.
Ann Intern Med 2003 Feb 4;138(3):197-207
Abstract

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human
immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM, Baker RK, Moorman AC, et al
Clin Infect Dis 2003 Feb 1;36(3):363-7
Abstract

Hepatitis C and human immunodeficiency virus infection.
Thomas DL.
Hepatology 2002 Nov;36(5 Suppl):S201-9
Abstract

Hepatitis C and HIV-1 coinfection.
Mohsen AH, Easterbrook P, Taylor CB, Norris S.
Gut 2002 Oct;51(4):601-8
Abstract

Is hepatitis C virus co-infection associated with survival in HIV-infected patients
treated by combination antiretroviral therapy?
Rancinan C, Neau D, Saves M, Lawson-Ayayi S,et al.
AIDS 2002 Jul 5;16(10):1357-62
Abstract

Hepatitis C infection is not associated with systemic HIV-associated non-hodgkin's
lymphoma: A cohort study.
Waters L, Stebbing J, Mandalia S, et al
Int J Cancer. 2005 Mar 8;
Abstract

Conference Reports, Abstracts, and Posters

HCV co-infection and risk of acute myocardial and cerebrovascular disease among HIV-infected patients
in the pre-HAART and HAART eras
R. Bedimo, A. Westfall, M. Mugavero, et al
(XVII International AIDS Conference)
Abstract

Integrating HIV prevention with hepatitis C co-infection programs
L. Scaccabarrozzi
(XVII International AIDS Conference)
Abstract

Genomic analysis of hepatitis C viral factors related to IFN response in HIV-co-infected patients
F. Bolcic, L. Bull , M.L. Martinez, et al
(XVII International AIDS Conference)
Abstract

The effect of HCV genotype on mortality among HIV-co-infected individuals receiving antiretroviral treatment
within a populational cohort
N.A. Jahnke, B. Yip, V.D. Lima, et al
(XVII International AIDS Conference)
Abstract

Evidences of GBV-C viral interference on HIV-HCV co-infection
G.L. Baggio-Zappia , A.J. Barbosa, M.K.C. Brunialti, et al
(XVII International AIDS Conference)
Abstract

POWERPOINT PRESENTATION
Mental Health, Substance Use, and HIV/HCV Coinfection Treatment
J Weiss
(XVII International AIDS Conference)
Report

POWERPOINT PRESENTATION
A summary of state of the art in non-invasive diagnosis of liver disease, liver transplantation, and
treatments on the horizon for hepatitis virus co-infected patients
J Rockstroh,
(XVII International AIDS Conference)
Report

POSTER
Efficacy of Pegylated Interferon + Ribavirin Treatment in HIV/HCV-co-infected Patients Receiving
Abacavir + Lamivudine or Tenofovir + either Lamivudine or Emtricitabine as Nucleoside Analogue
Backbone
J Mira, L Lopez-Cortes, P Barreiro, et al
(15 CROI)
PDF Poster Abstract

POSTER
HIV/HCV Co-infection Results in Increased T Cell Activation and Impaired IL-7-mediated
T LymphocyteHomeostasis: Possible Exploitation as Predictors of Anti-HCV Therapy Response
G Marchetti, M Bongiovanni, V Pegorer, et al
PDF Poster Abstract|

POSTER
Influence of HIV, HCV, and HIV/HCV-co-infection on Level, Phenotype, and Activation Status of
Foxp3⁺CD4⁺ Regulatory T Cells
N Rallon, M Lopez, V Soriano, et al
(15 CROI)
PDF Poster Abstract

HCV-specific CD4⁺ T Cell Responses Can Be Primed in Acute Concomitant HIV/HCV Co-infection
and Are Preserved by Early ART
J Schulze zur Wiesch, D Pieper
(15 CROI)